Lamogin 25 mg is an antiepileptic and mood-stabilizing medication containing Lamotrigine. It is indicated for the management of epilepsy and bipolar disorder in adults and children, depending on the specific condition and age group. Lamotrigine works by stabilizing neuronal membranes and modulating excitatory neurotransmitter release, thereby reducing the frequency and severity of seizures or mood episodes.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Primary Antiepileptic Drug

Indications

Epilepsy – Combination Therapy (Patients ≥ 2 years):

• Partial-onset seizures

• Primary generalized tonic-clonic seizures

• Generalized seizures of Lennox-Gastaut syndrome

Epilepsy – Monotherapy (Patients ≥ 16 years):

• Partial-onset seizures

Bipolar Disorder – Adults:

• Maintenance therapy to delay mood episode recurrence

Lamogin is used either as monotherapy or adjunctive therapy depending on patient age, type of seizure, or co-administered drugs.

Pharmacology

Lamotrigine exerts its therapeutic effects primarily by:

• Inhibiting voltage-sensitive sodium channels

• Stabilizing neuronal membranes

• Reducing the presynaptic release of excitatory neurotransmitters, such as glutamate and aspartate

These actions prevent abnormal neuronal firing in the brain, controlling seizures and stabilizing mood.

Dosage & Administration

Epilepsy – Monotherapy (≥ 16 years):

• Start: 25 mg once daily for 14 days

• Titrate to 50 mg daily for next 14 days

• Increase by 50 mg/day every 7–14 days

• Maintenance: 225–375 mg/day in 1–2 divided doses

Adjunctive Therapy with Valproate (Adults ≥ 12 years):

• Start: 25 mg on alternate days for 14 days

• Gradual increase to 100–200 mg/day (1–2 divided doses)

Adjunctive Therapy with Enzyme-Inducing Drugs (without Valproate):

• Adults ≥ 12 years: 50 mg once daily initially, titrate to 300–500 mg/day in 2 divided doses

Bipolar Disorder – Adults:

• Monotherapy: Start at 25 mg once daily; maintenance 200 mg/day

• Adjunctive with Valproate: Start 25 mg alternate days; maintenance 100 mg/day

• Adjunctive with enzyme-inducing drugs: Titrate from 50 mg daily up to 400 mg/day

Pediatric Patients (2–12 years):

• Initial dosing based on weight, gradually titrated

• Maintenance: 4.5–15 mg/kg/day depending on co-administered drugs

Administration:

• Oral tablets taken with or without food

• Follow strict titration schedules to minimize risk of serious skin reactions

Interactions

Lamogin interacts with:

• Oral contraceptives

• Valproate (increases Lamotrigine levels)

• Carbamazepine, Phenytoin, Phenobarbital, Primidone (may reduce Lamotrigine levels)

• Lithium, Levetiracetam, Lopinavir/ritonavir, Atazanavir/ritonavir, Olanzapine, Pregabalin

Contraindications

• Known hypersensitivity to Lamotrigine or ingredients

• History of severe rash or allergic reactions to Lamotrigine

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common adverse effects include:

• Dizziness, tremor, headache, blurred vision

• Rash, abdominal pain, vomiting, diarrhea

• Sleepiness, insomnia, fever, infections, back pain

• Serious: serious skin rashes (SJS/TEN), blood dyscrasias, suicidal behavior, aseptic meningitis

Precautions & Warnings

• Serious skin reactions: follow titration schedule closely

• Monitor for suicidal ideation

• Use with caution in hepatic or renal impairment

• Gradual dose adjustment recommended during co-administration with other antiepileptics or mood stabilizers

Overdose

Overdose may cause:

• Ataxia, nystagmus, seizures

• Decreased consciousness, coma

• Intraventricular conduction delay

Management: supportive care and monitoring

Pregnancy & Lactation

• Pregnancy Category C: Use only if benefits outweigh risks

• Excreted in breast milk; caution advised

Storage Conditions

• Store below 30°C, away from light and moisture

• Keep out of reach of children

Mode of Action

Lamotrigine inhibits voltage-gated sodium channels, stabilizes neuronal membranes, and suppresses glutamate release. It has weak interactions with multiple receptors, including serotonin, GABA, dopamine, adrenergic, histamine, and opioid receptors, which may contribute to its efficacy in both epilepsy and bipolar disorder.

Pediatric Use

• Safety and efficacy as adjunctive therapy in children <2 years not established

• Bipolar disorder: safety not established for ages 10–17 years.